![Alain Dugal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 7 490 $ as of 2026-05-30
Mr. Alain R.
Dugal is a Chief Operating Officer & Executive Vice President at LSL Pharma Group, Inc. Mr. Dugal was previously employed as a Vice President-Manufacturing & Logistics by Crescita Therapeutics, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LSL PHARMA GROUP INC 0.02% | 2026-05-27 | 29,487 ( 0.02% ) | 7 490 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| LSL PHARMA GROUP INC. | Chief Operating Officer | 2026-05-27 |
| Companies | Position | End |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Corporate Officer/Principal | 2021-09-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Crescita Therapeutics, Inc.
 Crescita Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the production and development of topical products for treating medical conditions in dermatology and pain | Health Technology |
LSL Pharma Group, Inc.
 LSL Pharma Group, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops, manufactures and distributes natural health products & dietary supplements | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
